Cambridge Investment Research Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $543K | Sell |
1,891
-7,288
| -79% | -$2.09M | ﹤0.01% | 2462 |
|
|
2025
Q1 | $2.83M | Buy |
9,179
+2,211
| +32% | +$682K | 0.01% | 1136 |
|
|
2024
Q4 | $2.46M | Sell |
6,968
-4,208
| -38% | -$1.48M | 0.01% | 1213 |
|
|
2024
Q3 | $4.01M | Buy |
11,176
+8,589
| +332% | +$3.08M | 0.01% | 933 |
|
|
2024
Q2 | $824K | Buy |
2,587
+907
| +54% | +$289K | ﹤0.01% | 1909 |
|
|
2024
Q1 | $386K | Sell |
1,680
-11
| -0.7% | -$2.53K | ﹤0.01% | 2499 |
|
|
2023
Q4 | $372K | Sell |
1,691
-14
| -0.8% | -$3.08K | ﹤0.01% | 2437 |
|
|
2023
Q3 | $385K | Buy |
1,705
+141
| +9% | +$31.8K | ﹤0.01% | 2298 |
|
|
2023
Q2 | $345K | Sell |
1,564
-4,539
| -74% | -$1M | ﹤0.01% | 2423 |
|
|
2023
Q1 | $1.37M | Buy |
6,103
+4,291
| +237% | +$961K | 0.01% | 1364 |
|
|
2022
Q4 | $504K | Buy |
1,812
+37
| +2% | +$10.3K | ﹤0.01% | 2007 |
|
|
2022
Q3 | $372K | Buy |
1,775
+298
| +20% | +$62.5K | ﹤0.01% | 2188 |
|
|
2022
Q2 | $348K | Buy |
+1,477
| New | +$348K | ﹤0.01% | 2247 |
|